Homeβ€ΊSearchβ€ΊNature Reviews Clinical Oncology

Nature Reviews Clinical Oncology

Nature Publishing Group Β· United Kingdom Β· Est. 1965

ISSN1759-4782
SJR Q1βœ“ WOS SCIEβœ“ Scopus / SJR
96
/ 100
High Trust
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
β—† WoS flagship (SCIE/SSCI/AHCI)78
βœ“ Corroboration (3 more)+18
Total96
Level data: Norwegian Register (HK-dir), NLOD 2.0. Β· Third-party records Β· how this is calculated Β· Report an error β†’
⚑ Speed vs Prestige
How does this journal balance review speed with impact level?
Publication speed: not measurable
publisher doesn’t disclose per-article submission dates β€” we never estimate
Q1
SJR Rank
Top 25% in field
Impact Factor & Quartile Β· Web of Science (JCR)

βœ“ Indexed in the Web of Science Core Collection (SCIE) β€” Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page β†—

The Impact Factor & JCR quartile are licensed by Clarivate β€” we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei
28.076
H-Indexi
281
CiteScore
ViewΒ β†—
Scopus metric Β· on the journal’s page
SNIPi
14.181
Total Worksi
3,331
Total Citationsi
290,620
2yr Mean Citednessi
23.15
Open Impact Factor alternative
Retractions
1
Source: Retraction Watch

Aims & Scope

Nature Reviews Clinical Oncology publishes authoritative review articles, research highlights, and opinion pieces on all aspects of clinical oncology. The journal covers the latest advances in cancer research, diagnosis, treatment, and prevention, with a focus on translating scientific discoveries into clinical practice. It aims to provide a comprehensive overview of the current state of oncology and to highlight future directions for research and patient care.

General Information

Country / RegionUnited Kingdom
Primary LanguageEnglish
1st Year Published1965
FrequencyMonthly
StatusActive (last: 2026)
Total Publications3,331
Publisher OrgNature Portfolio
Visit Journal Website

Submission Info

Peer ReviewPeer-reviewed
Review Timeβ€”
Acceptance Rateβ€”
OA Licenseβ€”
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes

Think.Check.Submit Compliance

7/12 Β· 58%
βœ…
Do you know the journal / publisher?
Nature Publishing Group
βœ…
Does the journal have a website?
βœ“ Linked
βœ…
Is the ISSN verified?
1759-4782
βœ…
Indexed in a trusted database?
WoS, Scopus
βœ…
Peer review process documented?
Peer-reviewed
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
❌
Long-term digital preservation?
N/A
❌
Plagiarism detection in place?
N/A
❌
Listed in DOAJ (verified OA)?
N/A
βœ…
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
156
21k
2019
146
27k
2020
130
27k
2021
124
15k
2022
133
14k
2023
128
6.7k
2024
131
1.6k
2025
69
55
2026

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category β€” its quartile can differ by discipline.

OncologyQ1

Subject Classification

Web of Science Categories

Oncology

Scopus Categories

Oncology

Research Topics (OpenAlex)

Cancer Genomics and DiagnosticsLung Cancer Treatments and MutationsCancer Immunotherapy and BiomarkersCAR-T cell therapy researchColorectal Cancer Treatments and StudiesChronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and TreatmentHER2/EGFR in Cancer ResearchCancer Treatment and PharmacologyLung Cancer Research Studies

Frequently asked questions about Nature Reviews Clinical Oncology

Is Nature Reviews Clinical Oncology a predatory journal?

PubScope has no integrity flags on record for Nature Reviews Clinical Oncology: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee β€” always confirm fit and policies before submitting.

What is the impact factor of Nature Reviews Clinical Oncology?

Nature Reviews Clinical Oncology is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β€” including Arts & Humanities and Emerging Sources titles β€” receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 23.15.

Is Nature Reviews Clinical Oncology indexed in Scopus and Web of Science?

Nature Reviews Clinical Oncology is indexed in Web of Science, Scopus.

What is the aims and scope of Nature Reviews Clinical Oncology?

Nature Reviews Clinical Oncology publishes authoritative review articles, research highlights, and opinion pieces on all aspects of clinical oncology. The journal covers the latest advances in cancer research, diagnosis, treatment, and prevention, with a focus on translating scientific discoveries into clinical practice. It aims to provide a comprehensive overview of the current state of oncology and to highlight future directions for research and patient care.

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref